Latest Thyroid neoplasm Stories
Unsurpassed Performance in Identifying Benign and Malignant Thyroid Nodules, with Negative Predictive Value of 94% and Positive Predictive Value of 74% in Combination with ThyGenX(TM)(1) PARSIPPANY,
Combined Platform Test Achieved High Negative Predictive Value (NPV) of 94% and Positive Predictive Value (PPV) of 74% PARSIPPANY, N.J., March 9, 2015 /PRNewswire/ -- PDI, Inc.
- Data Presented This Week at ENDO 2015 Annual Meeting - SOUTH SAN FRANCISCO, Calif., March 6, 2015 /PRNewswire/ -- Veracyte,
-- Nexavar is the only approved treatment for patients with RAI-refractory differentiated thyroid cancer -- Nexavar significantly extended progression-free survival
Researchers make use of the microgravity environment aboard the space station to seek answers to questions about the nature of cancer cells.
SOUTH SAN FRANCISCO, Calif., May 6, 2014 /PRNewswire/ -- Veracyte, Inc.
A new analysis has found that adolescents and young adults who develop thyroid cancer as a secondary cancer have a significantly greater risk of dying than those with primary thyroid cancer.
A specific protein once thought to exist only in the brain may play a crucial role in a deadly form of thyroid cancer, as well as other cancers, and provide a fresh target for researchers seeking ways to stop its progression
Researchers at the National Institutes of Health (NIH), Bethesda, MD, have taken the first steps to determine if a protein, called Programmed Death Ligand 1 (PD-L1), can help to predict which thyroid cancer patients will most likely have a recurrence of the disease.
- A serpent whose bite was fabled to produce intense thirst.